Literature DB >> 25708898

The Protective Effects of Exclusive Enteral Nutrition Formulas on Growth Factor Expression and the Proximal Tibial Epiphyseal Growth Plate in a TNBS-Induced IBD Rat Model.

Jieru Shi1, Zhiheng Huang, Yuhuan Wang, Ying Huang.   

Abstract

OBJECTIVE: This study aimed to evaluate the effectiveness of different types of nutritional formulas in a rat model of TNBS-induced IBD.
METHODS: IBD was induced with TNBS in 4-week-old rats that were then fed different exclusive enteral nutrition diets for 7 days. The length of the tibia and the number of chondrocytes in the proximal tibias were analyzed at 7 days after supplementation. Immunohistochemical analysis, ELISA and real-time PCR were performed to evaluate the levels of growth hormone receptor (GHR) and insulin-like growth factor-I receptor (IGF-IR), the growth factors IGF-I and insulin-like growth factor-binding protein-3 (IGFBP3) , bone morphogenetic protein (BMP)-2 and BMP-6 respectively.
RESULTS: The results demonstrated that the tibia length of the peptide formula group was longer than that of the IBD-Modulen(®) formula and normal diet groups (P < 0.05). Furthermore, the number of chondrocytes of the proximal tibial was more pronounced in the peptide formula group compared to the other groups (P < 0.05). The peptide formula was also more effective in increasing the expression of GHR compared to the other groups (P < 0.05), while the expression of IGF-IR was not significantly different (P > 0.05). In addition, the IGF-I and IGFBP3 levels were more pronounced in the peptide formula supplement group (P < 0.05), and the expression of BMP-2 and BMP-6 mRNA in the proximal tibia growth plate from the peptide formula group was higher than that in the ordinary formula and normal diet groups (P < 0.05).
CONCLUSIONS: EEN, and particularly a peptide formula, exerted protective effects on the proximal tibial epiphyseal growth plate in a TNBS-induced IBD model.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25708898     DOI: 10.1007/s10620-015-3582-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Risk of diagnosed fractures in children with inflammatory bowel diseases.

Authors:  Michael D Kappelman; Joseph A Galanko; Carol Q Porter; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

2.  Exclusive enteral nutrition in the treatment of children with Crohn's disease in Sweden: a questionnaire survey.

Authors:  Josefin M Gråfors; Thomas H Casswall
Journal:  Acta Paediatr       Date:  2011-02-22       Impact factor: 2.299

3.  The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation.

Authors:  S C Wong; A Smyth; E McNeill; P J Galloway; K Hassan; P McGrogan; S F Ahmed
Journal:  Clin Endocrinol (Oxf)       Date:  2010-02-23       Impact factor: 3.478

4.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

Authors: 
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

Review 6.  Treatment of inflammatory bowel disease (IBD).

Authors:  Anand B Pithadia; Sunita Jain
Journal:  Pharmacol Rep       Date:  2011       Impact factor: 3.024

7.  BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells.

Authors:  O Mizrahi; D Sheyn; W Tawackoli; I Kallai; A Oh; S Su; X Da; P Zarrini; G Cook-Wiens; D Gazit; Z Gazit
Journal:  Gene Ther       Date:  2012-06-21       Impact factor: 5.250

8.  Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease.

Authors:  A Tenore; W F Berman; J S Parks; A M Bongiovanni
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

Review 9.  Pathophysiology and management of abnormal growth in children with chronic inflammatory bowel disease.

Authors:  S F Ahmed; C Farquharson; P McGrogan; R K Russell
Journal:  World Rev Nutr Diet       Date:  2013-02-11       Impact factor: 0.575

Review 10.  Inflammatory bowel disease: clinical aspects and treatments.

Authors:  Marc Fakhoury; Rebecca Negrulj; Armin Mooranian; Hani Al-Salami
Journal:  J Inflamm Res       Date:  2014-06-23
View more
  1 in total

1.  Intestinal inflammation without weight loss decreases bone density and growth.

Authors:  Regina Irwin; Sandi Raehtz; Narayanan Parameswaran; Laura R McCabe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.